TrialAnnals of the rheumatic diseases2018

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea.

Fengchun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.